beta Amyloid 1-16 Antikörper
-
- Target
- beta Amyloid 1-16
- Reaktivität
- Human, Maus
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (IHC), ELISA
- Spezifität
- Reacts with human and mouse Aβ1-16 as well as other Aβ peptides: Aβ37, Aβ38, Aβ39, Aβ40, and Aβ42
- Aufreinigung
- Purified
- Immunogen
- Aggregated Abeta1-42, fibrillar Abeta.
- Klon
- Ab5
- Isotyp
- IgG2b
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
1 -10 μg/mL for any application - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS, pH 7.4
- Handhabung
- Dilute in PBS or medium which is identical to that used in the assay system.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Stable for at least one year at -20°C
- Haltbarkeit
- 12 months
-
-
Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice." in: Frontiers in molecular neuroscience, Vol. 10, pp. 144, (2017) (PubMed).
: "
-
Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice." in: Frontiers in molecular neuroscience, Vol. 10, pp. 144, (2017) (PubMed).
-
- Target
- beta Amyloid 1-16
- Andere Bezeichnung
- Amyloid beta 1-16
- Hintergrund
- Amyloid beta A4 protein ABPP APPI, APP Alzheimer disease amyloid protein Cerebral vascular amyloid peptide, CVAP PreA4 Protease nexin-II, PN-II Gene name: APP, A4, AD1
- Gen-ID
- 351
- UniProt
- P05067
-